
|Videos|July 3, 2017
Is One Immunotherapy for Lung Cancer Better Than the Rest?
Author(s)Melissa L. Johnson, MD
This video reviews immunotherapy options now available for the treatment of lung cancer across different lines of therapy.
Advertisement
In this video, Melissa L. Johnson, MD, of Sarah Cannon Research Institute in Nashville, Tennessee, reviews immunotherapy options now available for the treatment of lung cancer across different lines of therapy and highlights upcoming research in this setting.
Johnson gave a presentation on this topic during an education session at the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting last month in Chicago.
Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on CancerNetwork
1
2026 Tandem Meetings: What’s the Latest Research in Multiple Myeloma?
2
Modifiable Risk Factors Suggest Potential for Improving Cancer Prevention
3
ASCO President Elect Talks Advancing Patient-Centered Care and Team-Based Innovation
4
Dato-DXd Receives Priority Review in Unresectable/Metastatic TNBC
5






































